Targeting AKR1B1 reprograms tumor-associated macrophages to enhance antitumor immunity.
靶向 AKR1B1 可重编程肿瘤相关巨噬细胞,从而增强抗肿瘤免疫力。
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-014043
Liu Yuqing, Zhou Chao, Tang Yabin, Lei Huimin, Aihemaiti Ayinazhaer, Liu Hongyu, Zou Peichen, Xie Junting, Guo Xu, Xia Ruixue, Han Bao-Hui, Chen Hongzhuan, Zhu Liang